Lina Marouf, MD
Retina Specialist · San Antonio, TXNPI 1700999273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,118 and has fallen 77.2% since, to $254 in 2025.
Across 85 payments — averaging $44.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$637
- Genentech USA, Inc.$516
- Regeneron Healthcare Solutions, Inc.$430
- Alcon$426
- Biotissue Holdings Inc.$425
- Astellas Pharma US Inc$264
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,74999%
- Entertainment$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $637 |
| Genentech USA, Inc. | 10 | $516 |
| Regeneron Healthcare Solutions, Inc. | 14 | $430 |
| Alcon | 4 | $426 |
| Biotissue Holdings Inc. | 3 | $425 |
| Astellas Pharma US Inc | 3 | $264 |
| Apellis Pharmaceuticals, Inc. | 5 | $222 |
| Alimera Sciences, Inc. | 6 | $221 |
| Novartis | 5 | $185 |
| Amgen | 1 | $122 |
| Aerie Pharmaceuticals, Inc. | 2 | $114 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| Sun Pharmaceutical Industries Inc. | 1 | $44 |
| Optos, Inc. | 1 | $32 |
| Ocular Therapeutix, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,781 in reported general payments places this provider in the 60th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 26 | $296 |
| Dorzolamide Hcl | 12 | $189 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in San Antonio
- Moises ChicaSan Antonio$43K
- Sarah HolySan Antonio$18K
- Richard LaneSan Antonio$17K
- Duncan FriedmanSan Antonio$9K
- Thomas OeiSan Antonio$9K
- Timothy ClelandSan Antonio$6K
- Dianne BarrettSan Antonio$4K
- Abumere AkinwaleSan Antonio$3K
- Rushil RaoSan Antonio$3K
- Enchun LiuSan Antonio$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.